NAUT (Nautilus Biotechnology) ROE % Adjusted to Book Value: -11.41% (As of Mar. 2026)


NAUT Nautilus Biotechnology Inc NAUT
28 GF Score
Price $2.06
! 2 Warning Signs
View Full Analysis

What is Nautilus Biotechnology ROE % Adjusted to Book Value?

Nautilus Biotechnology NAUT -11.89% 28 ROE % Adjusted to Book Value is -11.41% as of Mar. 2026. GuruFocus rates NAUT with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Nautilus Biotechnology's ROE % for the quarter that ended in Mar. 2026 was -39.01%. Nautilus Biotechnology's PB Ratio for the quarter that ended in Mar. 2026 was 3.42. Nautilus Biotechnology's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -11.41%.

Nautilus Biotechnology ROE % Adjusted to Book Value Related Terms

Nautilus Biotechnology ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Nautilus Biotechnology's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nautilus Biotechnology ROE % Adjusted to Book Value Chart

Nautilus Biotechnology Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -17.03 -24.04 -15.57 -29.27 -20.55

Nautilus Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.88 -62.80 -49.22 -21.54 -11.41

NAUT vs IFRX, NMRA, IRD: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Nautilus Biotechnology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nautilus Biotechnology ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nautilus Biotechnology's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Nautilus Biotechnology's ROE % Adjusted to Book Value falls into.


NAUT
28GF Score
Nautilus Biotechnology Inc NAUT
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nautilus Biotechnology ROE % Adjusted to Book Value Calculation

Nautilus Biotechnology's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-32.27% / 1.57
=-20.55%

Nautilus Biotechnology's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-39.01% / 3.42
=-11.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -11.41% mean?
Nautilus Biotechnology (NAUT) has a ROE % Adjusted to Book Value of -11.41% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Nautilus Biotechnology and its competitors.
Is Nautilus Biotechnology's ROE % Adjusted to Book Value too high?
Nautilus Biotechnology's current ROE % Adjusted to Book Value is -11.41%. Overall, Nautilus Biotechnology has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Nautilus Biotechnology's ROE % Adjusted to Book Value compare to IFRX and NMRA?
Nautilus Biotechnology's ROE % Adjusted to Book Value of -11.41% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Nautilus Biotechnology and its competitors. Nautilus Biotechnology's current ROE % Adjusted to Book Value is -11.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nautilus Biotechnology stock overvalued right now?
Nautilus Biotechnology (NAUT) has a current ROE % Adjusted to Book Value of -11.41%. The current ROE % Adjusted to Book Value is -11.41%. Nautilus Biotechnology's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Nautilus Biotechnology (NAUT), the current ROE % Adjusted to Book Value is -11.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nautilus Biotechnology Business Description

Address 2701 Eastlake Avenue East, Seattle, WA, USA, 98102
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
28GF Score

Get the complete analysis for NAUT

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.06
Price